CVS Health Corp (NYSE:CVS)
| 94.53 Delayed Data As of Jun 24 |  +2.16 / +2.34%Today’s Change | 79.33 Today|||52-Week Range 111.25 | -8.37% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Lynch Karen S President & Chief Executive Officer |  Sale | 4/01/2022 | 116,940 | $101.09 | $11.8M | -6.50% |
Moriarty Thomas M /medco/ General Counsel & Executive Vice President | Sale | 4/01/2022 | 105,854 | $101.09 | $10.7M | -6.50% |
Roberts Jonathan C Chief Operating Officer & Executive Vice President | Sale | 11/03/2021 | 108,870 | $95.00 | $10.3M | -1.89% |
Brennan Troyen A Chief Medical Officer & Executive Vice President | Sale | 4/01/2022 | 77,960 | $101.09 | $7.9M | -6.50% |
Roberts Jonathan C Chief Operating Officer & Executive Vice President | Sale | 1/27/2022 | 68,482 | $107.50 | $7.4M | -11.49% |
Brennan Troyen A Chief Medical Officer & Executive Vice President | Sale | 10/26/2021 | 80,802 | $88.00 | $7.1M | +7.02% |
Roberts Jonathan C Chief Operating Officer & Executive Vice President |  Buy | 1/27/2022 | 68,482 | $102.26 | $7.0M | -11.49% |
Brennan Troyen A Chief Medical Officer & Executive Vice President | Sale | 2/03/2022 | 47,937 | $110.00 | $5.3M | -13.06% |
Roberts Jonathan C Chief Operating Officer & Executive Vice President | Buy | 11/03/2021 | 108,870 | $45.93 | $5.0M | -1.89% |
Brennan Troyen A Chief Medical Officer & Executive Vice President | Buy | 2/03/2022 | 47,937 | $102.26 | $4.9M | -13.06% |
Page of 9